H. pylori Eradication Cuts Gastric Cancer Risk in Those With Family History
Gastric cancer risk reduced among those with H. pylori infection plus first - degree relatives with gastric cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 5, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Infections, Internal Medicine, Oncology, Pathology, Pharmacy, Journal, Source Type: news

H. pylori Eradication Cuts Gastric Cancer Risk in Those With Family History
WEDNESDAY, Feb. 5, 2020 -- Among those who have Helicobacter pylori infection and a family history of gastric cancer in first-degree relatives, eradication treatment for H. pylori reduces the risk for gastric cancer, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2020 Category: Pharmaceuticals Source Type: news

H pylori Therapy Reduces Gastric Cancer in High-Risk Patients H pylori Therapy Reduces Gastric Cancer in High-Risk Patients
Treatment and especially eradication of H pylori infection dramatically reduces the incidence of gastric cancer in high-risk patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 30, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

A molecular switch for stomach disease
(University of Erlangen-Nuremberg) A research team from Friedrich-Alexander-Universit ä t Erlangen-N ü rnberg (FAU) has revealed a new mechanism which controls the causes of infection with H. pylori, triggering the development of stomach diseases. It is hoped that these findings will lead in time to new therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2020 Category: International Medicine & Public Health Source Type: news

Watchdog rejects use of genetic disorders drug in the NHS
NICE will not approve volanesorsen on the NHS Related items fromOnMedica NICE recommends Herceptin for gastric cancer H. pylori eradication linked to reduced risk of gastric cancer Use of DPP-4 inhibitors associated with increased risk of IBD Aspirin could also treat cancer, research suggests Antivirals cut liver cancer risk after hepatitis C (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 6, 2020 Category: UK Health Source Type: news

Gastric cancer susceptibility marker discovered
(Institut Pasteur) Gastric cancer is often associated with a poor prognosis because it tends to be diagnosed at an advanced stage. To reduce the death rate, it is essential to identify a biomarker enabling early diagnosis of this cancer. In pursuit of this goal, scientists analyzed the mechanisms involved in the development of gastric cancer during infection by the bacterial pathogen Helicobacter pylori. As a result, they were able to identify a potential susceptibility marker. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - December 17, 2019 Category: Biology Source Type: news

Eliminating Helicobacter pylori May Significantly Decrease Gastric Cancer Risk
Successfully eliminating  Helicobacter pylori from a patient’s gastrointestinal tract could lead to a significant decrease in gastric cancer risk. (Source: CancerNetwork)
Source: CancerNetwork - December 13, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Cochrane China Network working groups meeting - November 2019
Cochrane China Network working groups had an informal meeting included in the 13th China Health Technology Assessment Forum, hosted by Prof Yingyao Chen (from Fudan University) on 17th November.Eight Cochrane China Network working groups reported their work on Cochrane and some achievements in health technology assessment Cochrane. Prof Jianping Liu (Beijing University of Chinese medicine) gave the opening session, and introduced Cochrane China network and the whole session.Prof Shiyao Chen, from Zhongshan hospital affiliated to Fudan University, talked about “The clinical decision on screening helicobacter pylori fo...
Source: Cochrane News and Events - December 6, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

H. Pylori Infection Must Be Wiped Out to Cut Gastric Cancer Risk
Risk for gastric cancer tied to H. pylori infection higher in blacks, Asians, Hispanics/Latinos (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 21, 2019 Category: Cancer & Oncology Tags: Gastroenterology, Infections, Oncology, Pathology, Journal, Source Type: news

H. Pylori Infection Must Be Wiped Out to Cut Gastric Cancer Risk
THURSDAY, Nov. 21, 2019 -- Only complete eradication of Helicobacter pylori infection, not treatment alone, will reduce the risk for developing stomach cancer, according to a study recently published in Gastroenterology. Shria Kumar, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2019 Category: Pharmaceuticals Source Type: news

Eliminating common bacterial infection significantly decreases gastric cancer risk
(University of Pennsylvania School of Medicine) Penn researchers are first to assess Helicobacter pylori infection and gastric cancer risk in Americans, certain demographics and ethnic groups. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2019 Category: Cancer & Oncology Source Type: news

FDA Approves Talicia (omeprazole magnesium, amoxicillin and rifabutin) for the Treatment of H. pylori Infection in Adults
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 04, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the“Company”), a specialty biopharmaceutical company primarily focused... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 4, 2019 Category: Drugs & Pharmacology Source Type: news

FDA OKs First Rifabutin-Based H Pylori Therapy Talicia FDA OKs First Rifabutin-Based H Pylori Therapy Talicia
Talicia combines omeprazole, amoxicillin, and rifabutin and is designed to address growing bacterial resistance to standard clarithromycin-based H pylori therapy.FDA Approvals (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 4, 2019 Category: Intensive Care Tags: Infectious Diseases News Alert Source Type: news

U.S. FDA approves RedHill's bacterial infection treatment
RedHill Biopharma Ltd's said on Monday its three-drug combination therapy to treat Helicobacter pylori bacterial infections had been approved by the U.S. Food and Drug Administration, sending its shares up 25%. (Source: Reuters: Health)
Source: Reuters: Health - November 4, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: Could turmeric help solve the antibiotic resistance crisis?
New research uses nanocapsules that contain curcumin, the main ingredient in turmeric, to tackle antibiotic resistant strains of Helicobacter pylori. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 28, 2019 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Cancer-causing stomach bug has become TWICE as hard to treat with antibiotics in the last 20 years
Rates of resistance of Helicobacter pylori against clarithromycin jumped from under 10 per cent in 1998 to almost 22 per cent last year, according to French scientists. (Source: the Mail online | Health)
Source: the Mail online | Health - October 21, 2019 Category: Consumer Health News Source Type: news

Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
Follow up study (n=1214, Taiwan) found eradication of H pylori infection has minimal disruption on microbiota, no effect on antibiotic resistance of E coli, and some positive effects on metabolic parameters, lending support to long-term safety of H pylori eradication therapy. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 2, 2019 Category: Consumer Health News Source Type: news

Kenya: Kenyans Share Harrowing Experiences With H.pylori
[Nairobi News] If you haven't spent sleepless nights and uncomfortable days trying to get treatment for the notorious Helicobacter Pylori (H.pylori) then you are one of the lucky few in Nairobi who would not relate to this article. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 26, 2019 Category: African Health Source Type: news

Kenya: A Stomach Bacteria Threatens Nairobi's Residents. What Can Be Done to Stop It
[The Conversation Africa] The spread of Helicobacter Pylori (H.pylori) has been flagged as a public health concern in Nairobi due to poor urban sanitation and access to clean water. It's a concern because it's contagious, is present in the city's water systems and is hard to treat. If left untreated, it can cause inflammation and even cancer. Kimang'a Nyerere explains what H.pylori is and what needs to be done to better manage infection rates. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 25, 2019 Category: African Health Source Type: news

H. Pylori Treatment May Reduce Gastric Cancer Incidence, Death
THURSDAY, Sept. 12, 2019 -- Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation are associated with a reduced risk for gastric cancer mortality, according to a study published online Sept. 11 in The BMJ. Wen-Qing Li,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 12, 2019 Category: Pharmaceuticals Source Type: news

H. pylori eradication linked to reduced risk of gastric cancer
Gastric cancer incidence and death half as likely over 22 years after short-term H. pylori treatment Related items fromOnMedica Antivirals cut liver cancer risk after hepatitis C Statins might not cut colorectal cancer risk after all Antibiotics, H2RAs and PPIs linked to child obesity Long-term use of PPIs linked to doubling in stomach cancer risk Taking aspirin with a PPI reduces risk of oesophageal cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 12, 2019 Category: UK Health Source Type: news

Diabetes Linked to Increased Risk of Gastric Cancer After H. Pylori Eradication Diabetes Linked to Increased Risk of Gastric Cancer After H. Pylori Eradication
Diabetes appears to increase the risk of gastric cancer after Helicobacter pylori eradication, especially in patients with suboptimal glycemic control, according to a database study.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 10, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

An Updated Approach to Treatment of H. pylori Infection An Updated Approach to Treatment of H. pylori Infection
This paper summarizes indications for H. pylori testing, available diagnostic tests, and treatment approaches, with a focus on the growing challenges of antibiotic resistance.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

T2DM Increases Gastric Cancer Risk After H. Pylori Eradication
Targeted screening should be considered in high - risk patients following H. pylori eradication therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 23, 2019 Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Infections, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

T2DM Increases Gastric Cancer Risk After H. Pylori Eradication
TUESDAY, July 23, 2019 -- Type 2 diabetes mellitus increases the risk for gastric cancer after treatment for Helicobacter pylori infection, according to a study published online July 11 in Diabetes Care. Ka Shing Cheung, M.B.B.S., M.P.H., from The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 23, 2019 Category: Pharmaceuticals Source Type: news

PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers PPI, H2RA Equally Good at Preventing Bleeding Recurrence in H. Pylori-Negative Ulcers
Lansoprazole and famotidine have comparable effects in preventing recurrent idiopathic gastroduodenal ulcer bleeding, a two-year randomized clinical trial shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Susceptibility-Guided vs Empiric Therapy for H. pylori Susceptibility-Guided vs Empiric Therapy for H. pylori
How do these treatment strategies for H pylori compare in terms of achieving eradication?Alimentary Pharmacology & Therapeutics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 1, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

How gastric stem cells fight bacteria
Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by researchers from Charité - Universitätsmedizin Berlin and the Max Planck Institute for Infection Biology, which describes what happens during a Helicobacter pylori infection of the human stomach. By actively fighting the colonizing bacteria, gastric stem cells protect themselves against damage that can lead to cancer. (Source: World Pharma News)
Source: World Pharma News - June 25, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

How gastric stem cells fight bacteria
(Charit é - Universit ä tsmedizin Berlin) Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by researchers from Charit é - Universit ä tsmedizin Berlin, which describes what happens during a Helicobacter pylori infection of the human stomach. By actively fighting the colonizing bacteria, gastric stem cells protect themselves against damage that can lead to cancer. Results from this study have been published in Nature Cell Biology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 25, 2019 Category: Biology Source Type: news

H pylori Raises Phosphate Binder Pill Burden in Dialysis H pylori Raises Phosphate Binder Pill Burden in Dialysis
If those with Helicobacter pylori don't take a proton pump inhibitor or sodium bicarbonate, they have a higher phosphate binder pill burden, researchers report, between six and nine tablets a day.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2019 Category: Consumer Health News Tags: Nephrology News Source Type: news

Infection biology: Signs of selection in the stomach
(Ludwig-Maximilians-Universit ä t M ü nchen) Helicobacter pylori, a globally distributed gastric bacterium, is genetically highly adaptable. Microbiologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have now characterized its population structure in individual patients, demonstrating an important role of antibiotics for its within-patient evolution. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: How do cancer-causing bacteria take over our stomachs?
H. pylori live in the stomachs of around 50% of all humans. Despite their prevalence, little is known about how they can survive inside us for a lifetime. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 8, 2019 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

RedHill Biopharma Submits New Drug Application for Talicia for H. pylori Infection
TEL-AVIV, Israel and RALEIGH, N.C., May 7, 2019 -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the“Company”), a specialty biopharmaceutical company primarily focused on... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 7, 2019 Category: Drugs & Pharmacology Source Type: news

Image of the Day: Gastric Colonies
Scientists map the presence of Helicobacter pylori in the stomach of mice, showing where the bacteria colonize the gastric glands. (Source: The Scientist)
Source: The Scientist - May 6, 2019 Category: Science Tags: Image of the Day Source Type: news

Machine Learning Model to Predict Recurrent Ulcer Bleeding Machine Learning Model to Predict Recurrent Ulcer Bleeding
The authors present a novel clinical and laboratory parameter-based prediction model to predict recurrent ulcer bleeding in patients with a history of H. pylori-negative idiopathic bleeding ulcers.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 6, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pathogens find safe harbor deep in the gastric glands
(PLOS) Scientists have long tried to understand how pathogenic bacteria like Helicobacter pylori, a risk factor for stomach ulcers and cancer, survive in the harsh environment of the stomach. In a new study publishing May 2 in the open-access journal PLOS Biology, researchers led by Connie Fung and Manuel Amieva at Stanford University propose that H. pylori exploit a specialized niche that provides safe harbor deep in the gastric glands to maintain lifelong colonization. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 2, 2019 Category: Cancer & Oncology Source Type: news

Reservoir bugs: Stanford-led study shows why stomach pathogen is so tough to eradicate
(Stanford Medicine) Once the stomach-dwelling bacteria Helicobacter pylori is established in the stomach, Stanford University School of Medicine investigators have learned that even competing strains of the same species can't displace it. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 2, 2019 Category: Infectious Diseases Source Type: news

Gut Brain Axis
Helicobacter pylori Induced Anxiety and AnorexiaOurPGP9.5 was used as a Hypothalamic Neuronal Marker in this study-Hajime Suzuki, Koji Ataka, Akihiro Asakawa, Kai-Chun Cheng, Miharu Ushikai, Haruki Iwai, Takakazu Yagi, Takeshi Arai, Kinnosuke Yahiro, Katsuhiro Yamamoto, Yoshito Yokoyama, Masayasu Kojima, Toshihiko Yada, Toshiya Hirayama, Norifumi Nakamura& Akio Inui (2019).Helicobacter pylori Vacuolating Cytotoxin A Causes Anorexia and Anxiety via Hypothalamic Urocortin 1 in Mice. Scientific Reports volume 9, Article number: 6011.Images: Ucn1- and DAPI-positive cells (yellow arrow heads), or Ucn1- and PGP9.5-positive c...
Source: Neuromics - April 17, 2019 Category: Neuroscience Tags: Gut-Brain Axis. Hypothalamus Helicobacter pylori Hypothalamic Neurons PGP9.5 Antibody Protein Gene Product 9.5 Source Type: news

New study explains how inflammation causes gastric cancer
(Kanazawa University) Researchers from Kanazawa University and the Japan Agency for Medical Research and Development have solved the decades-old mystery of how stomach bacterium Helicobacter pylori causes gastric cancer. Using mouse models and human cancer cell lines, they showed that inflammation resulting from bacterial infection leads to the proliferation of gastric epithelial cells, which ultimately form gastric tumors. By blocking the protein pathway responsible for this proliferation, they prevented gastric tumor formation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 16, 2019 Category: Biology Source Type: news

Cancer prevention drug also disables H. pylori bacterium
(Vanderbilt University Medical Center) A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 28, 2019 Category: Cancer & Oncology Source Type: news

Study reveals key details about bacterium that increases risk for stomach cancer
More than half of the people in the world host colonies of a bacterium called Helicobacter pylori in their stomachs.Although it ’s harmless to many, H. pylori can cause stomach cancer as well as ulcers and other gastric conditions. Doctors tend to prescribe multiple antibiotics to defeat the microbe, but that strategy can lead to antibiotic-resistant superbugs.Now, afinding by UCLA scientists may lead to a better approach. The researchers have determined the molecular structure of a protein that enables H. pylori to stay alive in the stomach, and elucidated the mechanism by which that protein works.Z. Hong Zhou, the ...
Source: UCLA Newsroom: Health Sciences - March 25, 2019 Category: Universities & Medical Training Source Type: news

< i > H. pylori < /i > ( < i > Helicobacter Pylori < /i > ) Infection
Title:H. pylori (Helicobacter Pylori) InfectionCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/20/2019 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - March 20, 2019 Category: Nutrition Source Type: news

Honey and black cumin found to treat H. Pylori patients
(Natural News) Helicobacter pylori – or H. pylori – infections are fairly common, with more than half the world’s population likely walking around with these bacteria in their gut. Nonetheless, they are responsible for the majority of ulcers of the small intestine and stomach, and are becoming increasingly difficult to treat. New “superbug” type antibiotic-resistant strains... (Source: NaturalNews.com)
Source: NaturalNews.com - March 9, 2019 Category: Consumer Health News Source Type: news

Infection biology: What makes Helicobacter so adaptable?
(Ludwig-Maximilians-Universit ä t M ü nchen) The bacterial pathogen Helicobacter pylori owes its worldwide distribution to its genetic adaptability. Ludwig-Maximilians-Universitaet Munich microbiologists have identified an enzyme that plays a vital role in the flexible control of global gene expression in the species. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 12, 2019 Category: Infectious Diseases Source Type: news

Houston Consensus Conference on H. pylori Infection Testing Houston Consensus Conference on H. pylori Infection Testing
This paper presents guidelines for implementing testing for H. pylori infection in U.S. health care systems, with a focus on identifying target populations for diagnosis and therapy.Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 10, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication Metformin Tied to Lower Gastric Cancer Risk After H. Pylori Eradication
Metformin use is associated with a lower risk of gastric cancer in diabetic patients after eradication of H. pylori, researchers from Hong Kong report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mangoes for digestive health: A compound found in the fruit was found to be effective against H. pylori
(Natural News) The next big thing in cancer treatment might just come from a fruit we all know — mangoes. A study published in the African Journal of Traditional, Complementary and Alternative Medicines revealed that mangiferin, a bioactive compound found in mangoes, may reduce the likelihood of gastric cancer induced by the bacteria Helicobacter pylori (H. pylori). In... (Source: NaturalNews.com)
Source: NaturalNews.com - October 27, 2018 Category: Consumer Health News Source Type: news

H. Pylori Antibodies May Point to Colorectal Cancer Risk H. Pylori Antibodies May Point to Colorectal Cancer Risk
Antibodies to Vacuolating cytotoxin A (VacA), one of the major toxins secreted by Helicobacter pylori, show a relationship with colorectal cancer, according to a large study of serum.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 23, 2018 Category: Pathology Tags: Gastroenterology News Source Type: news

H. Pylori Ups CRC Risk in Some Ethnic Groups
(MedPage Today) -- And high antibody levels tied to greater incidence in black and Asian patients (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 15, 2018 Category: Gastroenterology Source Type: news